ACE2 and COVID-19: Animal studies have shown that the expression of ACE2 in ACEIs/ARBs-treated mice is significantly increased.37 Diabetic patients treated with ACEIs show elevated circulating ACE2 levels.38 All these factors explain why COVID-19 is less infectivity in children, show mild symptoms and recover quickly.